On Invalid Date, Kezar Life Sciences (NASDAQ: KZR) reported Q4 2023 earnings per share (EPS) of -$0.44, up 76% year over year. Total Kezar Life Sciences earnings for the quarter were -$32.26 million. In the same quarter last year, Kezar Life Sciences's earnings per share (EPS) was -$0.25.
As of Q2 2024, Kezar Life Sciences's earnings has grown year over year. Kezar Life Sciences's earnings in the past year totalled -$101.87 million.
What is KZR's earnings date?
Kezar Life Sciences's earnings date is Invalid Date. Add KZR to your watchlist to be reminded of KZR's next earnings announcement.
What was KZR's revenue last quarter?
On Invalid Date, Kezar Life Sciences (NASDAQ: KZR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kezar Life Sciences's revenue was $0.00.
What was KZR's revenue growth in the past year?
As of Q2 2024, Kezar Life Sciences's revenue has grown null year over year. Kezar Life Sciences's revenue in the past year totalled $7.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.